Kathrin Böpple

588 total citations
10 papers, 408 citations indexed

About

Kathrin Böpple is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Kathrin Böpple has authored 10 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Kathrin Böpple's work include Ubiquitin and proteasome pathways (2 papers), Mitochondrial Function and Pathology (2 papers) and 3D Printing in Biomedical Research (2 papers). Kathrin Böpple is often cited by papers focused on Ubiquitin and proteasome pathways (2 papers), Mitochondrial Function and Pathology (2 papers) and 3D Printing in Biomedical Research (2 papers). Kathrin Böpple collaborates with scholars based in Germany, Estonia and Denmark. Kathrin Böpple's co-authors include Walter E. Aulitzky, Simon Heine, Markus Kleih, Frank Eßmann, Meng Dong, Andrea Gaißler, Monilola A. Olayioye, Andreas S. Thum, Heiko van der Kuip and Dolors Colomer and has published in prestigious journals such as PLoS ONE, Cancer Research and Cell Death and Disease.

In The Last Decade

Kathrin Böpple

10 papers receiving 407 citations

Peers

Kathrin Böpple

MB

ONCOL

CR

PFM

BE

Zdeněk Škrott Czechia

Matheus Molina Silva Brazil

Maike Zimmermann United States

Afshin Nikkhoo Iran

Sara L. O’Kane United Kingdom

Mandar Bhonde India

Sung-Won Shin South Korea

Luca Sorvillo Italy

Sabrina Blondy France

Zdeněk Škrott Czechia

Kathrin Böpple

169 ×0.7

MB

103 ×1.0

ONCOL

57 ×0.8

CR

43 ×0.8

PFM

42 ×0.9

BE

Citations per year, relative to Kathrin Böpple Kathrin Böpple (= 1×) peers Zdeněk Škrott

Countries citing papers authored by Kathrin Böpple

Since Specialization

Citations

This map shows the geographic impact of Kathrin Böpple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Böpple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Böpple more than expected).

Fields of papers citing papers by Kathrin Böpple

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Böpple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Böpple. The network helps show where Kathrin Böpple may publish in the future.

Co-authorship network of co-authors of Kathrin Böpple

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Böpple. A scholar is included among the top collaborators of Kathrin Böpple based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Böpple. Kathrin Böpple is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Böpple, Kathrin, Yaara Oren, Whitney S. Henry, et al.. (2024). ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC. Cell Death and Disease. 15(4). 290–290. 7 indexed citations

2.

Dong, Meng, Kathrin Böpple, Bernd Winkler, et al.. (2023). Perfusion Air Culture of Precision-Cut Tumor Slices: An Ex Vivo System to Evaluate Individual Drug Response under Controlled Culture Conditions. Cells. 12(5). 807–807. 7 indexed citations

3.

Hückelhoven‐Krauss, Angela, Alexander Kunz, Tim Sauer, et al.. (2023). Impact of serum‑free media on the expansion and functionality of CD19.CAR T‑cells. International Journal of Molecular Medicine. 52(1). 7 indexed citations

4.

Weller, Sandra, Kathrin Böpple, Ute Hofmann, et al.. (2022). The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA. Cell Death Discovery. 8(1). 215–215. 21 indexed citations

5.

Kappelmann‐Fenzl, Melanie, Mahshid Monavari, Gaëlle Letort, et al.. (2021). 3D Spheroids Versus 3D Tumor‐Like Microcapsules: Confinement and Mechanical Stress May Lead to the Expression of Malignant Responses in Cancer Cells. Advanced Biology. 5(7). e2000349–e2000349. 10 indexed citations

6.

Kleih, Markus, Kathrin Böpple, Meng Dong, et al.. (2019). Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death and Disease. 10(11). 851–851. 299 indexed citations

7.

Heine, Simon, Markus Kleih, Kathrin Böpple, et al.. (2018). Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA. Journal of Hematology & Oncology. 11(1). 112–112. 26 indexed citations

8.

Kleih, Markus, Simon Heine, Kathrin Böpple, et al.. (2018). Abstract 3522: Both mitochondrial function and composition of BCL2 family proteins determines sensitivity to Cisplatin in ovarian cancer cells and are promising targets to overcome Cisplatin resistance in ovarian cancer. Cancer Research. 78(13_Supplement). 3522–3522. 1 indexed citations

9.

Böpple, Kathrin, et al.. (2017). Anatomy and behavioral function of serotonin receptors in Drosophila melanogaster larvae. PLoS ONE. 12(8). e0181865–e0181865. 28 indexed citations

10.

Böpple, Kathrin, et al.. (1971). A multiplex switch for multidetector experiments. Nuclear Instruments and Methods. 94(1). 7–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact